KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Revenue (2016 - 2025)

Precigen (PGEN) has disclosed Revenue for 14 consecutive years, with $5.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Revenue rose 645.47% to $5.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.1 million, a 202.45% increase, with the full-year FY2022 number at $14.6 million, up 9.11% from a year prior.
  • Revenue was $5.1 million for Q3 2025 at Precigen, up from $34000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $13.1 million in Q4 2022 to a low of -$7.0 million in Q3 2022.
  • A 5-year average of $50473.7 and a median of $31000.0 in 2024 define the central range for Revenue.
  • Peak YoY movement for Revenue: crashed 167.3% in 2024, then skyrocketed 645.47% in 2025.
  • Precigen's Revenue stood at -$4.8 million in 2021, then soared by 375.92% to $13.1 million in 2022, then plummeted by 138.13% to -$5.0 million in 2023, then skyrocketed by 99.56% to -$22000.0 in 2024, then soared by 23109.09% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Revenue are $5.1 million (Q3 2025), $34000.0 (Q2 2025), and $23000.0 (Q1 2025).